Advantary Capital Partners
Sarah Johnson, Ph.D., MBA, is a Partner at Advantary Capital Partners, with previous experience as Head of US Business Development at Oricell Therapeutics and Director of Business Development at Legend Biotech. Sarah holds a Ph.D. in Chemistry from Princeton University and an MBA from Drexel University's LeBow College of Business. Prior roles include Senior Manager of Business Development at Aro Biotherapeutics, Licensing Manager at Drexel University, and Technology Licensing Officer at the University of Pennsylvania. Sarah's academic background includes serving as a Graduate Teaching Assistant and Undergraduate Teaching Assistant at prestigious institutions, along with research assistant positions at both the University of Pennsylvania and The Wistar Institute.
This person is not in any teams
This person is not in any offices
Advantary Capital Partners
Investment Advantary and our capital partners invest in traditional buyouts, management buyouts, and rollups where we believe our expertise can drive transformation that unlocks the potential of great companies. We are committed to a long-term investment approach. This allows us and our management teams to focus on the actions necessary to create, drive and maximize sustainable long-term value. Team and Services Our team of extraordinary operating partners and advisors have deep operating, execution, turnaround, and investment experience. We leverage these skills for our portfolio and for select non-portfolio companies.